Nicotinic acetylcholine receptors (AChRs) are ligand-gated ion channels that have been widely conserved throughout evolution and are implicated in numerous physiological and pathological processes in humans. In order to identify new regulators of nicotinic neurotransmission, we have performed a genetic screen for mutants which survive chronic exposure to lethal doses of the nematode-specific nicotinic agonist levamisole. We report here the identification and characterization of the novel protein MOLO-1 (modulator of levamisole receptor-1), which is required for efficient nicotinic neurotransmission at the neuromuscular synapse. MOLO-1 is a small type 1 transmembrane protein. MOLO-1 is expressed in muscle cells where it localizes specifically to synapses which contain the levamisole-sensitive AChR (L-AChR). Electrophysiological analysis of
molo-1 mutant animals shows that the synaptic currents associated with L-AChRs are reduced by over 60%. In order to measure the surface expression of L-AChR in vivo, we have developed a novel C. elegans strain in which an affinity tag is recombined into the
unc-29 L-AChR subunit locus. Surprisingly, the reduction in synaptic current is not associated with a reduction in the number of receptors at synapses in
molo-1 mutants. In contrast, in animals which do not express the receptor, MOLO-1 is no longer detectable at synapses, suggesting an association between MOLO-1 and the L-AChR. We have recently been able to functionally reconstitute the levamisole-sensitive AChR in Xenopus oocytes (Boulin, 2008). Taking advantage of this system, we have now shown that co-expression of MOLO-1 with L-AChR leads to a two fold increase of the measured current compared to L-AChR alone. This result is fully consistent with our in vivo findings and strongly suggests that MOLO-1 has a direct effect on the receptor. MOLO-1 could function by modifying the biophysical properties of the receptor (gating, open probability, conductance). In order to test this hypothesis, we are conducting single channel recordings in primary cultured C. elegans muscle cells. In addition we are using single molecule fluorescence imaging (Ulbrich, 2007) in Xenopus oocytes to establish the relative stoechiometry of MOLO-1 and L-AChR. Taken together, our results suggest that the transmembrane protein MOLO-1 could directly modulate the electrophysiological properties of the AChR making it the first positive modulator of a nicotinic receptor.